NasdaqGS:CARLMedical Equipment
Carlsmed (CARL) Revenue Growth At 85.9% Tests Bearish Profitability Narratives
Carlsmed (CARL) has reported its FY 2025 fourth quarter with total revenue of US$15.2 million and a basic EPS loss of US$0.32, while on a trailing twelve month basis revenue was US$50.5 million and basic EPS was a loss of US$2.12. The company has seen quarterly revenue move from US$9.4 million in Q4 2024 to US$15.2 million in Q4 2025, as basic EPS shifted from a loss of US$1.14 to a loss of US$0.32 over the same period, setting up a story where faster top line expansion is still being weighed...

